DrugPatentWatch Database Preview
XOLAIR Drug Profile
Summary for Tradename: XOLAIR
| Patents: | 95 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
Pharmacology for XOLAIR
| Mechanism of Action | IgE-directed Antibody Interactions |
| Physiological Effect | Decreased IgE Activity |
US Patents for XOLAIR
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Try a Free Trial | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Try a Free Trial | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Try a Free Trial | BIONANOPLUS, S.L. (Noain-Navarra, ES) | ➤ Try a Free Trial | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Try a Free Trial | ATOPIX THERAPEUTICS LIMITED (London, GB) | ➤ Try a Free Trial | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Try a Free Trial | SUNSHINE LAKE PHARMA CO., LTD. (Dongguan, Guangdong, CN) | ➤ Try a Free Trial | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Try a Free Trial | LegoChem Biosciences, Inc. (Daejeon, KR) | ➤ Try a Free Trial | RX | search | |
| Genentech | XOLAIR | omalizumab | VIAL | 103976 | 001 | 2003-06-20 | ➤ Try a Free Trial | Banner Life Sciences LLC (High Point, NC) | ➤ Try a Free Trial | RX | search | |
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Patent Expiration | Status | Orphan | Source |
International Patents for XOLAIR
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2008128228 | ➤ Try a Free Trial |
| Japan | 2015509936 | ➤ Try a Free Trial |
| Russian Federation | 2650767 | ➤ Try a Free Trial |
| Japan | 6024025 | ➤ Try a Free Trial |
| China | 106833535 | ➤ Try a Free Trial |
| New Zealand | 573732 | ➤ Try a Free Trial |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for XOLAIR
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 92780 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: TRASTUZUMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20130826 |
| 93138 | Luxembourg | ➤ Try a Free Trial | PRODUCT NAME: RITUXIMAB ET HYALURONIDASE HUMAINE RECOMBINANTE; FIRST REGISTRATION DATE: 20140326 |
| CA 2015 00043 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: TRASTUZUMAB OG REKOMBINANT HUMAN HYALURONIDASE; REG. NO/DATE: C(20135603) /EU/1/00/145/002 20130826 |
| CR 2016 00031 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: RITUXIMAB AND RECOMBINANT HUMAN HYALURONIDASE; NAT. REG. NO/DATE: EU/1/98/067/003-004 20140326; FIRST REG. NO/DATE: EU EU/1/98/067 20140326 |
| 122016000049 | Germany | ➤ Try a Free Trial | PRODUCT NAME: RITUXIMAB UND REKOMBINANTE HUMANE HYALURONIDASE; NAT. REGISTRATION NO/DATE: EU/1/98/067/003 20140321; FIRST REGISTRATION: EU EU/1/98/067/003 20140621 |
| PA2016022 | Lithuania | ➤ Try a Free Trial | PRODUCT NAME: RITUKSIMABAS; REGISTRATION NO/DATE: EU/1/98/067/001-002 20140321 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
